logo
    • English
      • 简体中文
      • 繁體中文
  • Home
  • Articles
    • Insights
    • Client Press Releases
    • Client Coverage
  • Interviews
    • CEO Interview
    • PDAC Interview
  • Clients
    • Featured Companies
    • In-depth Analysis
  • Markets
    • Stock Tracker
    • Markets at a glance
    • Investing 101
      • Investing in Mining 101
        • Gold and Precious Metals
        • Electric and Battery Metals
        • Base Metals
        • Other Mining Subsectors
  • METALS 100
  • GCFF Event
    • Next Event
    • Past Events
  • Home
  • Biotechnology
Filter

Biotechnology

Categories

Sectors

Locations

Exchange

医疗保健精选——Astellas在日本提交roxadustat申请,OpGen携手大华基因展开冠状病毒测试服务

Healthcare Roundup – Astellas files application in Japan, OpGen up 6% on planned coronavirus testing service

Jan 30, 2020

Life Science

亚马逊员工不得到中国,除非冠状病毒传播有“进一步通知”

Amazon restricts employee travel to China ‘until further notice’ as coronavirus spreads

Jan 29, 2020

Life Science, Technology

医疗保健精选——强生疫苗对决冠状病毒,Selecta Biosciences下跌5.17%

Healthcare Roundup – J&J enters coronavirus fray with planned vaccine, Selecta Biosciences -5.7%

Jan 29, 2020

Life Science

冠状病毒恐惧情绪,香港股市应声下跌近3%

Hong Kong Stock Market Dives Nearly 3% on Coronavirus Fears

Jan 29, 2020

Life Science

武汉冠状病毒

Update: Biopharmas Developing Products for Wuhan Coronavirus Outbreak

Jan 29, 2020

Life Science

武汉的博沃生物与亚特兰大的GeoVax签署开发冠状病毒疫苗的意向书

Wuhan’s BravoVax Signs Letter of Intent with Atlanta’s GeoVax to Develop Coronavirus Vaccine

Jan 28, 2020

Life Science

医疗保健精选——Itamar拟发售3000万美元ADS,Hepion Pharma取得积极NASH数据

Healthcare Roundup  – Itamar -4.7% after filing for $30M ADS offering, Hepion Pharma +46% on positive NASH data

Jan 28, 2020

Life Science

Naturally Splendid Signs Agreement with Northridge Sales Group

Jan 28, 2020

Life Science

Technology Roundup – Guidewire gains a rare bear, Apple shares hit by China’s coronavirus worries

Jan 27, 2020

Life Science

控制冠状病毒爆发,中国科学家全力以赴

Chinese Scientists Provide Support to Control Coronavirus Outbreak

Jan 27, 2020

Life Science

TILT Biotherapeutics签约中国普米斯生物,用TILT-123治疗癌症

TILT Biotherapeutics Signs a Licensing Deal with Biotheus, Inc for Cancer Therapy with Oncolytic Virus TILT-123

Jan 27, 2020

Life Science

Sorrento Therapeutics拒绝了价值近10亿美元的收购报价

Sorrento Therapeutics Rejects Acquisition Bid Worth Nearly $1 Billion

Jan 27, 2020

Life Science

基石药业

CStone announces first patient dosed in the global proof-of-concept study of CS1001 in combination with Bayer’s regorafenib

Jan 24, 2020

Life Science

医疗保健精选——Innovative Industrial Properties公开发行,拜耳减持CRISPR Therapeutics股份

Healthcare Roundup – Innovative Industrial Properties prices public offering, Bayer cuts stake in CRISPR Therapeutics

Jan 24, 2020

Life Science

默克的Keytruda迎挑战,百济神州Tislelizumab鳞状非小细胞肺癌

BeiGene’s Tislelizumab Could Challenge Merck’s Keytruda in the Checkpoint Inhibitor Market

Jan 24, 2020

Life Science

Naturally Splendid Terminates Agreements

Jan 24, 2020

Life Science

宝洁监测中国冠状病毒

Procter & Gamble says it is monitoring China coronavirus and its impact on travel, consumer confidence

Jan 23, 2020

Life Science

歌禮製藥ASC22有望成為HBV一流免疫療法

Ascletis Received Approval of Clinical Trials in HBV Patients for ASC22, a Subcutaneously Administered PD-L1 Antibody

Jan 23, 2020

Life Science

  • ‹‹ Previous
  • 38
  • 39
  • 40
  • 41
  • 42
  • 43
  • 44
  • 45
  • 46
  • Next ››

We connect Investors to Opportunities.

Financial Market Data copyright © 2020 QuoteMedia. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges). RT=Real-Time, EOD=End of Day, PD=Previous Day. Market Data powered by QuoteMedia. Terms of Use.

 
QuoteMedia logo

Head Office

  • 2209 – 1111 Alberni Street
    Vancouver, BC Canada V6E 4V2
  • Phone: (604) 488-8878
  • Fax: (604) 488-0868
  • Toll Free: 1 (866) 833-5517
  • Email: [email protected]

Shanghai Office

  • 06 - 607, 6/f. No.800 Shangcheng
    Road Pudong New District Shanghai,
    China
  • Phone: 021-68883919
  • Fax: 021-68882879
  • Email: [email protected]

Important Links

  • Privacy Policy
  • Terms of Use
  • Content Partner
  • NAI500 Investor Relations Services
  • About Us
  • Contact Us

© 2026 NAI Interactive Ltd. All Rights Reserved

gcff

logo

Website Design Vancouver by Nirvana Canada